In the grueling quest for discovering more effective cancer treatment therapies, researchers every now and then come up with interesting breakthroughs, which flash rays of hope not only to the patients, but also for the drug manufacturers to capitalize upon the discoveries.
A research team, at the Houston University, has recently claimed that they developed a drug, which can block cancer cells from leaving the pancreas and spreading to other organs. In essence, the drug will work as a targeted therapy that will bind cancer-causing genes to kill them, the researchers claimed. In the context of the effectiveness of the drug under development, one of the researchers said that the drug was found to be very effective in treating pancreas cancer and as a superiority, the drug will not release any toxicity.
The drug is the first of its kind in terms of the approach of killing two genes at the same time, according a member of the research team; who further revealed that the usage of the drug can also be extended to liver and breast cancers.
Pancreatic cancer has assumed alarming proportions, impairing the quality of life among the patients and also wiping out several lives worldwide. According to the American Cancer Society, more than 44,000 people will die of pancreatic cancer in 2018 in USA, and simultaneously, about 55,000 cases will be diagnosed there.
However, the drug will not be administered in patients for a few years as the researchers are yet to ascertain every nook and corner of the possible risks and side effects.
The researchers believe the drug to be a potential alternative to chemotherapy in the future.